Phathom Pharmaceuticals, Inc. held its Annual Meeting of Stockholders and approved an amendment to its Certificate of Incorporation to eliminate personal liability of officers for breach of fiduciary duty. The stockholders also elected Class I directors and ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm. The company made changes to its non-employee director compensation program.